A cornerstone of New York City’s medical landscape, Mount Sinai Hospital has been named a 2025 Med Honors Top Hospital for its unwavering commitment to patient care, groundbreaking research, and innovative treatments. As the flagship hospital of the Mount Sinai Health System, this world-class institution has long been a leader in specialties such as cardiology, oncology, neurology, orthopedics, and transplant medicine. With a strong foundation in academic medicine, it serves as the primary teaching hospital for the Icahn School of Medicine at Mount Sinai, consistently driving advancements in medical science and patient outcomes.

Mount Sinai is home to the Recanati/Miller Transplantation Institute, a national leader in organ transplantation, specializing in liver, kidney, pancreas, and intestinal transplants. Its Cardiac Surgery Program is renowned for minimally invasive procedures, structural heart interventions, and high-risk cardiac surgeries. The Mount Sinai Tisch Cancer Center is at the forefront of precision oncology, offering cutting-edge immunotherapy, genetic profiling, and targeted cancer treatments. Additionally, Mount Sinai’s neurology and neurosurgery departments are internationally recognized for their expertise in stroke care, epilepsy treatment, and neurodegenerative disease research.

Beyond its medical achievements, Mount Sinai Hospital remains dedicated to medical education, research, and community health initiatives. The hospital is a pioneer in robotic-assisted surgeries, regenerative medicine, and artificial intelligence-driven diagnostics, ensuring that patients receive the most advanced, personalized treatments available. As a 2025 Med Honors Top Hospital, Mount Sinai continues to set the benchmark for clinical excellence, innovation, and compassionate healthcare.